Zi-Qiang Gu

This inventor holds 7 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Shanghai Curegene Pharmaceutical Co Ltd., Cephalon, Inc., Smithkline Beecham Corporation. Active years: 2000-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zi-Qiang Gu. Retrieved from https://idiyas.com/inventor/zi-qiang-gu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 2)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 8(Granted Patents)

Company Filing History:

2 out of 2

Shanghai Curegene Pharmaceutical Co Ltd.

Smithkline Beecham Corporation

patents

4. 4 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2025

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12410132 - Antiplatelet drugs and uses thereof (2025-09-09),

2. 11834413 - Antiplatelet drugs and uses thereof (2023-12-05),

3. 11234961 - Pamoate salt of monoamine anti-Parkinson's agents, method of preparation and use thereof (2022-02-01),

4. 10952958 - Donezil pamoate, method of preparation and use thereof (2021-03-23),

5. 10478395 - Pamoate salts and methods of use (2019-11-19),

6. 10272031 - Memantine pamoate, method of preparation and use thereof (2019-04-30),

7. 6083944 - Quinoline-containing .alpha.-ketoamide cysteine and serine protease (2000-07-04),

Title: The Innovative Contributions of Zi-Qiang Gu

Introduction

Zi-Qiang Gu is a prominent inventor based in Reston, VA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiplatelet drugs. With a total of 7 patents to his name, Gu's work has the potential to impact the treatment of vascular diseases.

Latest Patents

Among his latest patents is a groundbreaking disclosure related to antiplatelet drugs and their uses. This patent outlines compounds that exhibit activity in the inhibition of platelet aggregation. It also details pharmaceutical compositions that comprise these compounds and methods for treating vascular diseases through their administration. This innovative approach could lead to improved therapeutic options for patients suffering from related conditions.

Career Highlights

Throughout his career, Zi-Qiang Gu has worked with various organizations, including Shanghai Curegene Pharmaceutical Co Ltd. His expertise in pharmaceutical development has positioned him as a key figure in the industry, contributing to advancements in drug formulation and application.

Collaborations

Gu has collaborated with notable professionals in his field, including Yuanchao Zhang and Gongxin He. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Zi-Qiang Gu's contributions to the field of pharmaceuticals, particularly through his patents on antiplatelet drugs, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.